Sharekhan has come out with its third quarter (October-December’ 18) earnings estimates for the Pharma sector. The brokerage house expects Laurus Labs to report net profit at Rs. 17.8 crore down 48.3% year-on-year (up 13.4% quarter-on-quarter).
Net Sales are expected to increase by 14.8 percent Y-o-Y (down 6.5 percent Q-o-Q) to Rs. 550 crore, according to Sharekhan.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
